Tissue and serum levofloxacin concentrations in diabetic foot infection patients | Zendy

K. Oberdorfer | Zendy; Stefanie Swoboda | Zendy; A. Hamann | Zendy; U Baertsch | Zendy; Klaus Kusterer | Zendy; BertJan H. van den Born | Zendy; Torsten HoppeTichy | Zendy; Heiko Geiss | Zendy; Heike von Baum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tissue and serum levofloxacin concentrations in diabetic foot infection patients

Author(s) -

K. Oberdorfer,

Stefanie Swoboda,

A. Hamann,

U Baertsch,

Klaus Kusterer,

BertJan H. van den Born,

Torsten HoppeTichy,

Heiko Geiss,

Heike von Baum

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh412

Subject(s) - levofloxacin , medicine , ofloxacin , diabetic foot , debridement (dental) , diabetes mellitus , surgery , gastroenterology , microbiology and biotechnology , antibiotics , ciprofloxacin , biology , endocrinology

Levofloxacin has a high bioavailability and a broad antibacterial spectrum which covers the common pathogens found in acute and chronic diabetic foot infections. The purpose of our study was to determine the serum and tissue concentrations of levofloxacin when administered orally in patients with infected diabetic foot ulcers and to compare these values with microbiological findings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research